08:54 AM EST, 01/15/2025 (MT Newswires) -- Health care stocks rose premarket Wednesday as the Health Care Select Sector SPDR Fund (XLV) advanced by 0.8% and the iShares Biotechnology ETF (IBB) was 1.3% higher recently.

Keros Therapeutics ( KROS ) shares fell by over 26% after the company said it has voluntarily halted all dosing in its phase 2 TROPOS trial for cibotercept in patients with pulmonary arterial hypertension due to "new observations of pericardial effusion adverse events."